Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Benjamin Paluch's Stock Ratings
Roth MKM Analyst
Benjamin Paluch is an analyst at Roth MKM. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/21/2025
Overall Average Return
-13.8%
Smart Score
Overall Average Return Percentile
16th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/27/2024 | CGON | Buy Now | CG Oncology | $26.56 | 144.73% | Benjamin Paluch25% | → $65 | Initiates | → Buy | Get Alert |
| 08/27/2024 | REPL | Buy Now | Replimune Group | $9.35 | 81.85% | Benjamin Paluch25% | → $17 | Initiates | → Buy | Get Alert |
| 08/27/2024 | GNLX | Buy Now | Genelux | $2.74 | 264.98% | Benjamin Paluch25% | → $10 | Initiates | → Buy | Get Alert |
